CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

D M Mannino¹, A S Buist², T L Petty³, P L Enright⁴ and S C Redd¹

¹ Air Pollution and Respiratory Health Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA
² Oregon Health Sciences University, Portland, OR, USA
³ Health One, Denver, CO, USA
⁴ University of Arizona, Tuscon, AZ, USA

Correspondence to:
Correspondence to:
Dr D M Mannino, National Center for Environmental Health, Centers for Disease Control and Prevention, 1600 Clifton Road, MS E-17 Atlanta, GA 30333, USA;
dmannino{at}cdc.gov

Background: A study was undertaken to define the risk of death among a national cohort of US adults both with and without lung disease.

Methods: Participants in the first National Health and Nutrition Examination Survey (NHANES I) followed for up to 22 years were studied. Subjects were classified using a modification of the Global Initiative for Chronic Obstructive Lung Disease criteria for chronic obstructive pulmonary disease (COPD) into the following mutually exclusive categories using the forced expiratory volume in 1 second (FEV₁), forced vital capacity (FVC), FEV₁/FVC ratio, and the presence of respiratory symptoms: severe COPD, moderate COPD, mild COPD, respiratory symptoms only, restrictive lung disease, and no lung disease. Proportional hazard models were developed that controlled for age, race, sex, education, smoking status, pack years of smoking, years since quitting smoking, and body mass index.

Results: A total of 1301 deaths occurred in the 5542 adults in the cohort. In the adjusted proportional hazards model the presence of severe or moderate COPD was associated with a higher risk of death (hazard ratios (HR) 2.7 and 1.6, 95% confidence intervals (CI) 2.1 to 3.5 and 1.4 to 2.0), as was restrictive lung disease (HR 1.7, 95% CI 1.4 to 2.0).

Conclusions: The presence of both obstructive and restrictive lung disease is a significant predictor of earlier death in long term follow up.

Keywords: death; lung function, chronic obstructive lung disease; restrictive lung disease

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Haugnes, H. S., Aass, N., Fossa, S. D., Dahl, O., Brydoy, M., Aasebo, U., Wilsgaard, T., Bremnes, R. M. (2009). Pulmonary Function in Long-Term Survivors of Testicular Cancer. JCO 27: 2779-2786 [Abstract] [Full Text]  
• Medinas Amoros, M, Mas-Tous, C, Renom-Sotorra, F, Rubi-Ponseti, M, Centeno-Flores, M., Gorriz-Dolz, M. (2009). Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chronic Respiratory Disease 6: 75-80 [Abstract]  
• Rennard, S. I., Vestbo, J. (2008). Natural Histories of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 5: 878-883 [Abstract] [Full Text]  
• Rennard, S. I. (2008). Lessons from Multidisciplinary Cross-Fertilization: Chronic Obstructive Pulmonary Disease, Lung Cancer, and Heart Disease. Proc Am Thorac Soc 5: 865-868 [Abstract] [Full Text]  
• Godtfredsen, N. S., Lam, T. H., Hansel, T. T., Leon, M. E., Gray, N., Dresler, C., Burns, D. M., Prescott, E., Vestbo, J. (2008). COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J 32: 844-853 [Abstract] [Full Text]  
• Lee, T. A., Pickard, A. S., Au, D. H., Bartle, B., Weiss, K. B. (2008). Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease. ANN INTERN MED 149: 380-390 [Abstract] [Full Text]  
• Bridevaux, P-O, Gerbase, M W, Probst-Hensch, N M, Schindler, C, Gaspoz, J-M, Rochat, T (2008). Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 63: 768-774 [Abstract] [Full Text]  
• Gilmartin, G. S., Tamisier, R., Curley, M., Weiss, J. W. (2008). Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans. Am. J. Physiol. Heart Circ. Physiol. 295: H778-H785 [Abstract] [Full Text]  
• Suissa, S., Ernst, P., Vandemheen, K. L., Aaron, S. D. (2008). Methodological issues in therapeutic trials of COPD. Eur Respir J 31: 927-933 [Abstract] [Full Text]  
• Bednarek, M, Maciejewski, J, Wozniak, M, Kuca, P, Zielinski, J (2008). Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 63: 402-407 [Abstract] [Full Text]  
• Pellegrino, R., Brusasco, V., Viegi, G., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., Jensen, R., Johnson, D. C., MacIntyre, N., McKay, R., Miller, M. R., Navajas, D., Pedersen, O. F., Wanger, J. (2008). Definition of COPD: based on evidence or opinion?. Eur Respir J 31: 681-682 [Full Text]  
• Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., Jones, P. W., Mahler, D. A., Make, B., Miravitlles, M., Page, C. P., Palange, P., Parr, D., Pistolesi, M., Rennard, S. I., Rutten-van Molken, M. P., Stockley, R., Sullivan, S. D., Wedzicha, J. A., Wouters, E. F., on behalf of the American Thoracic Society/Europea, (2008). Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31: 416-469 [Abstract] [Full Text]  
• Smith, C.J.P., Gribbin, J., Challen, K.B., Hubbard, R.B. (2008). The impact of the 2004 NICE guideline and 2003 General Medical Services contract on COPD in primary care in the UK. QJM 101: 145-153 [Abstract] [Full Text]  
• Downs, S. H., Schindler, C., Liu, L.-J. S., Keidel, D., Bayer-Oglesby, L., Brutsche, M. H., Gerbase, M. W., Keller, R., Kunzli, N., Leuenberger, P., Probst-Hensch, N. M., Tschopp, J.-M., Zellweger, J.-P., Rochat, T., Schwartz, J., Ackermann-Liebrich, U., the SAPALDIA Team, (2007). Reduced Exposure to PM10 and Attenuated Age-Related Decline in Lung Function. NEJM 357: 2338-2347 [Abstract] [Full Text]  
• van der Toorn, M., Smit-de Vries, M. P., Slebos, D.-J., de Bruin, H. G., Abello, N., van Oosterhout, A. J. M., Bischoff, R., Kauffman, H. F. (2007). Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L1156-L1162 [Abstract] [Full Text]  
• Sin, D. D., Tan, W. C. (2007). Breaking Down the "Great Wall" of COPD Care in China. Am. J. Respir. Crit. Care Med. 176: 732-733 [Full Text]  
• Mannino, D. M., Braman, S. (2007). The Epidemiology and Economics of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 4: 502-506 [Abstract] [Full Text]  
• Pinto-Plata, V. M., Celli-Cruz, R. A., Vassaux, C., Torre-Bouscoulet, L., Mendes, A., Rassulo, J., Celli, B. R. (2007). Differences in Cardiopulmonary Exercise Test Results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease Stage Categories and Gender. Chest 132: 1204-1211 [Abstract] [Full Text]  
• Bellia, V., Pedone, C., Catalano, F., Zito, A., Davi, E., Palange, S., Forastiere, F., Incalzi, R. A. (2007). Asthma in the Elderly: Mortality Rate and Associated Risk Factors for Mortality. Chest 132: 1175-1182 [Abstract] [Full Text]  
• Rennard, S. I. (2007). Inflammation in COPD: a link to systemic comorbidities. ERR 16: 91-97 [Abstract] [Full Text]  
• Fimognari, F. L., Pasqualetti, P., Moro, L., Franco, A., Piccirillo, G., Pastorelli, R., Rossini, P. M., Incalzi, R. A. (2007). The Association Between Metabolic Syndrome and Restrictive Ventilatory Dysfunction in Older Persons. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 62: 760-765 [Abstract] [Full Text]  
• Sircar, K., Hnizdo, E., Petsonk, E., Attfield, M. (2007). Decline in lung function and mortality: implications for medical monitoring. Occup. Environ. Med. 64: 461-466 [Abstract] [Full Text]  
• Pasipanodya, J. G., Miller, T. L., Vecino, M., Munguia, G., Garmon, R., Bae, S., Drewyer, G., Weis, S. E. (2007). Pulmonary Impairment After Tuberculosis. Chest 131: 1817-1824 [Abstract] [Full Text]  
• Canoy, D., Pekkanen, J., Elliott, P., Pouta, A., Laitinen, J., Hartikainen, A.-L., Zitting, P., Patel, S., Little, M. P, Jarvelin, M.-R. (2007). Early growth and adult respiratory function in men and women followed from the fetal period to adulthood. Thorax 62: 396-402 [Abstract] [Full Text]  
• Purdue, M. P, Gold, L., Jarvholm, B., Alavanja, M. C R, Ward, M. H, Vermeulen, R. (2007). Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 62: 51-56 [Abstract] [Full Text]  
• Mannino, D M (2006). Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story.. Thorax 61: 1032-1034 [Full Text]  
• Lokke, A, Lange, P, Scharling, H, Fabricius, P, Vestbo, J (2006). Developing COPD: a 25 year follow up study of the general population.. Thorax 61: 935-939 [Abstract] [Full Text]  
• Fuhrman, C, Jougla, E, Nicolau, J, Eilstein, D, Delmas, M-C (2006). Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis. Thorax 61: 930-934 [Abstract] [Full Text]  
• Frostad, A, Soyseth, V, Haldorsen, T, Andersen, A, Gulsvik, A (2006). Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia. Thorax 61: 951-956 [Abstract] [Full Text]  
• Marsh, S., Aldington, S., Shirtcliffe, P., Weatherall, M., Beasley, R. (2006). Smoking and COPD: what really are the risks?. Eur Respir J 28: 883-884 [Full Text]  
• Jensen, H. H., Godtfredsen, N. S., Lange, P., Vestbo, J. (2006). Potential misclassification of causes of death from COPD. Eur Respir J 28: 781-785 [Abstract] [Full Text]  
• Mannino, D M (2006). Spirometric screening: does it work?. Thorax 61: 834-835 [Full Text]  
• Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav, E., Buist, A. S., Mannino, D. M. (2006). Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28: 523-532 [Abstract] [Full Text]  
• Stavem, K., Sandvik, L., Erikssen, J. (2006). Can Global Initiative for Chronic Obstructive Lung Disease Stage 0 Provide Prognostic Information on Long-term Mortality in Men?. Chest 130: 318-325 [Abstract] [Full Text]  
• Pellegrino, R., Brusasco, V., Crapo, R. O., Viegi, G., Wanger, J., Gustafsson, P., Miller, M. R., McKay, R. T., Casaburi, R., McIntire, N., Pedersen, O. F., Burgos, F., Jensen, R., Navajas, D. (2006). From the authors. Eur Respir J 27: 1323-1324 [Full Text]  
• Mannino, D M, Davis, K J (2006). Lung function decline and outcomes in an elderly population. Thorax 61: 472-477 [Abstract] [Full Text]  
• Rennard, S. I. (2006). Chronic Obstructive Pulmonary Disease: Linking Outcomes and Pathobiology of Disease Modification. Proc Am Thorac Soc 3: 276-280 [Abstract] [Full Text]  
• Ochs-Balcom, H. M., Grant, B. J.B., Muti, P., Sempos, C. T., Freudenheim, J. L., Trevisan, M., Cassano, P. A., Iacoviello, L., Schunemann, H. J. (2006). Pulmonary function and abdominal adiposity in the general population.. Chest 129: 853-862 [Abstract] [Full Text]  
• Mannino, D. M., Watt, G., Hole, D., Gillis, C., Hart, C., McConnachie, A., Davey Smith, G., Upton, M., Hawthorne, V., Sin, D. D., Man, S. F. P., Van Eeden, S., Mapel, D. W., Vestbo, J. (2006). The natural history of chronic obstructive pulmonary disease.. Eur Respir J 27: 627-643 [Full Text]  
• Vestbo, J, Hogg, J C (2006). Convergence of the epidemiology and pathology of COPD. Thorax 61: 86-88 [Abstract] [Full Text]  
• Yende, S, Waterer, G W, Tolley, E A, Newman, A B, Bauer, D C, Taaffe, D R, Jensen, R, Crapo, R, Rubin, S, Nevitt, M, Simonsick, E M, Satterfield, S, Harris, T, Kritchevsky, S B (2006). Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 61: 10-16 [Abstract] [Full Text]  
• Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., Jensen, R., Johnson, D. C., MacIntyre, N., McKay, R., Miller, M. R., Navajas, D., Pedersen, O. F., Wanger, J. (2005). Interpretative strategies for lung function tests. Eur Respir J 26: 948-968 [Full Text]  
• Mannino, D. M. (2005). "Haeso Cheonsik" and Chronic Obstructive Pulmonary Disease in Korea. Am. J. Respir. Crit. Care Med. 172: 795-796 [Full Text]  
• Shaukat, A., Freudenheim, J. L., Grant, B. J.B., Muti, P., Ochs-Balcom, H. M., McCann, S. E., Trevisan, M., Iacoviello, L., Schunemann, H. J. (2005). Is Being Breastfed as an Infant Associated with Adult Pulmonary Function?. J. Am. Coll. Nutr. 24: 327-333 [Abstract] [Full Text]  
• Johannessen, A, Omenaas, E R, Bakke, P S, Gulsvik, A (2005). Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 60: 842-847 [Abstract] [Full Text]  
• Behrendt, C. E. (2005). Mild and Moderate-to-Severe COPD in Nonsmokers: Distinct Demographic Profiles. Chest 128: 1239-1244 [Abstract] [Full Text]  
• Mehta, A. J., Henneberger, P. K., Toren, K., Olin, A-C. (2005). Airflow limitation and changes in pulmonary function among bleachery workers. Eur Respir J 26: 133-139 [Abstract] [Full Text]  
• Hunninghake, D. B. (2005). Cardiovascular Disease in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2: 44-49 [Abstract] [Full Text]  
• Rennard, S. I. (2005). Clinical Approach to Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease. Proc Am Thorac Soc 2: 94-100 [Abstract] [Full Text]  
• Calverley, P. (2004). Are Inhaled Corticosteroids Systemic Therapy for Chronic Obstructive Pulmonary Disease?. Am. J. Respir. Crit. Care Med. 170: 721-722 [Full Text]  
• Sutherland, E. R., Cherniack, R. M. (2004). Management of Chronic Obstructive Pulmonary Disease. NEJM 350: 2689-2697 [Full Text]  
• Molfino, N. A. (2004). Genetics of COPD. Chest 125: 1929-1940 [Abstract] [Full Text]  
• Schunemann, H (2004). Is there an association between impaired pulmonary function and mortality in never smokers?. Thorax 59: 81-81 [Full Text]  
• Hansell, A.L., Walk, J.A., Soriano, J.B. (2003). What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis. Eur Respir J 22: 809-814 [Abstract] [Full Text]  
• (2003). OTHER ARTICLES NOTED (25 Apr 2003 to 18 Jul 2003). Evid. Based Nurs. 6: e1-12 [Full Text]  
• Partridge, M R (2003). Patients with COPD: do we fail them from beginning to end?. Thorax 58: 373-375 [Full Text]